v3.26.1
Consolidated Statement of Changes in Shareholders' Equity - EUR (€)
Total
Preferred shares
Common shares
Share capital
Share premium
Retained earnings
Other reserves
Net income (loss)
Balance at beginning of period (in shares) at Dec. 31, 2022   14,000 80,212,000          
Balance at beginning of period at Dec. 31, 2022 € 54,151,000     € 4,011,308 € 379,636,745 € (272,213,000) € 819,000 € (58,103,000)
Net loss (7,570,000)             (7,570,000)
Actuarial (losses) gains on defined benefit obligations 394,000           394,000  
Foreign currency translation (loss) gain 276,000         994,000 (718,000)  
Total comprehensive income (loss) (6,900,000)         994,000 (324,000) (7,570,000)
Allocation of prior period loss 0         (58,103,000)   58,103,000
Exercise and subscription of equity instruments (in shares)     648,000          
Exercise and subscription of equity instruments 395,000     32,000 363,000      
Increase capital, net 0              
Share-based payment 4,256,000       4,256,000      
Balance at end of period (in shares) at Dec. 31, 2023   14,000 80,861,000          
Balance at end of period at Dec. 31, 2023 51,901,000     4,043,733 384,255,036 (329,323,000) 495,000 (7,570,000)
Net loss (49,471,000)             (49,471,000)
Actuarial (losses) gains on defined benefit obligations 36,000           36,000  
Foreign currency translation (loss) gain (504,000)           (504,000)  
Total comprehensive income (loss) (49,939,000)           (468,000) (49,471,000)
Allocation of prior period loss 0         (7,570,000)   7,570,000
Exercise and subscription of equity instruments (in shares)     1,137,000          
Exercise and subscription of equity instruments 94,000     57,000 37,000      
Increase capital, net (in shares)     1,833,000          
Increase capital, net 2,836,000     92,000 2,744,000      
Share-based payment 3,944,000       3,944,000      
Balance at end of period (in shares) at Dec. 31, 2024   14,000 83,830,000          
Balance at end of period at Dec. 31, 2024 8,834,000     4,192,221 390,979,449 (336,893,000) 27,000 (49,471,000)
Net loss (49,177,000)             (49,177,000)
Actuarial (losses) gains on defined benefit obligations 94,000           94,000  
Foreign currency translation (loss) gain 997,000           997,000  
Total comprehensive income (loss) (48,086,000)           1,091,000 (49,177,000)
Allocation of prior period loss 0         (49,471,000)   49,471,000
Exercise and subscription of equity instruments (in shares)     1,543,000          
Exercise and subscription of equity instruments 49,000     77,000 (28,000)      
Increase capital, net (in shares)     8,345,000          
Increase capital, net 14,932,000     417,000 14,515,000      
Share-based payment 2,567,000       2,567,000      
Balance at end of period (in shares) at Dec. 31, 2025   14,000 93,719,000          
Balance at end of period at Dec. 31, 2025 € (21,704,000)     € 4,686,661 € 408,033,490 € (386,365,000) € 1,118,000 € (49,177,000)
Balance at beginning of period (in shares) at Apr. 23, 2025 83,844,411              
Balance at end of period (in shares) at Apr. 24, 2025 92,189,798   92,175,723